Antoine Hollebecque

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 44

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of cancer

Cancers

JCO precision oncology

Gustave Roussy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gustave Roussy

France

Medical doctor :: Drug development department

Publications

Francesco Facchinetti, Yohann Loriot, Floriane Braye, Damien Vasseur, Rastislav Bahleda, Ludovic Bigot, Rémy Barbé, Catline Nobre, David Combarel, Stefan Michiels, Antoine Italiano, Cristina Smolenschi, Lambros Tselikas, Jean Yves Scoazec, Santiago Ponce-Aix, Benjamin Besse, Fabrice Andre, Ken A Olaussen, Antoine Hollebecque, Luc Friboulet
Understanding and Overcoming Resistance to Selective FGFR inhibitors Across FGFR2-Driven Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, Christophe Marzac, Stefan Michiels, Marco Tagliamento, Arnaud Bayle, Cristina Smolenschi, Madona Sakkal, Mihaela Aldea, Hela Sassi, Filippo Gustavo Dall'Olio, Noémie Pata-Merci, Sophie Cotteret, Alice Fiévet, Nathalie Auger, Luc Friboulet, Francesco Facchinetti, Arthur Géraud, Santiago Ponce, Antoine Hollebecque, Benjamin Besse, Jean Baptiste Micol, Antoine Italiano, Ludovic Lacroix, Etienne Rouleau
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients. NPJ precision oncology 8 (1) (2024)
Julieta Rodriguez, Capucine Baldini, Arnauld Bayle, Arnaud Pagès, François-Xavier Danlos, Damien Vasseur, Etienne Rouleau, Ludovic Lacroix, Beatriz Alonso de Castro, Vincent Goldschmidt, Lauren Seknazi, Antoine Hollebecque, Jean Marie Michot, Stephane Champiat, Aurélien Marabelle, Kaissa Ouali, Christophe Marzac, Santiago Ponce, Jean-Baptiste Micol, Nathalie Chaput, Christophe Massard, Antoine Italiano
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial. JCO precision oncology 8 (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, an Irreversible FGFR1-4 Inhibitor: Pooled Safety analysis of 469 patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Julieta Rodriguez, Capucine Baldini, Arnauld Bayle, Arnaud Pagès, François-Xavier Danlos, Damien Vasseur, Etienne Rouleau, Ludovic Lacroix, Beatriz Alonso de Castro, Vincent Goldschmidt, Lauren Seknazi, Antoine Hollebecque, Jean Marie Michot, Stephane Champiat, Aurélien Marabelle, Kaissa Ouali, Christophe Marzac, Santiago Ponce, Jean-Baptiste Micol, Nathalie Chaput, Christophe Massard, Antoine Italiano
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial. JCO precision oncology 8 (2024)
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, Christophe Marzac, Stefan Michiels, Marco Tagliamento, Arnaud Bayle, Cristina Smolenschi, Madona Sakkal, Mihaela Aldea, Hela Sassi, Filippo Gustavo Dall'Olio, Noémie Pata-Merci, Sophie Cotteret, Alice Fiévet, Nathalie Auger, Luc Friboulet, Francesco Facchinetti, Arthur Géraud, Santiago Ponce, Antoine Hollebecque, Benjamin Besse, Jean Baptiste Micol, Antoine Italiano, Ludovic Lacroix, Etienne Rouleau
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients. NPJ precision oncology 8 (1) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Neil H Segal, Jeanne Tie, Scott Kopetz, Michel Ducreux, Eric Chen, Rodrigo Dienstmann, Antoine Hollebecque, Matthew J Reilley, Elena Elez Fernandez, Jan Cosaert, Jason Cain, Yee Soo-Hoo, Nicola Hewson, Zachary A Cooper, Rakesh Kumar, Josep Tabernero
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer. British journal of cancer (2024)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer (2023)
Yoann Pradat, Julien Viot, Andrey A Yurchenko, Konstantin Gunbin, Luigi Cerbone, Marc Deloger, Guillaume Grisay, Loic Verlingue, Veronique Chung-Scott, Ismael Padioleau, Leonardo Panunzi, Stefan Michiels, Antoine Hollebecque, Gerome Jules-Clement, Laura Mezquita, Antoine Laine, Yohann Loriot, Benjamin Besse, Luc Friboulet, Fabrice Andre, Paul-Henry Cournede, Daniel Gautheret, Sergey I Nikolaev
Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer. Cancer discovery (2023)
Mihaela Aldea, Marco Tagliamento, Arnauld Bayle, Damien Vasseur, Véronique Vergé, Arianna Marinello, François-Xavier Danlos, Félix Blanc-Durand, Elsa Bernard, Luigi Cerbone, Maria Fernanda Mosele, Aline Renneville, Julien Hadoux, Yohann Loriot, Madona Sakkal, Aurore Vozy, Clementine Sarkozy, Cristina Smolenschi, Claudio Nicotra, Patricia Martin-Romano, Clementine Boccon-Gibod, Wafikaamira Habza, Julien Lazarovici, Santiago Ponce, Antoine Hollebecque, Christophe Marzac, Ludovic Lacroix, Fabrice Barlesi, Fabrice Andre, Benjamin Besse, Etienne Rouleau, Antoine Italiano, Jean-Baptiste Micol
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 7 (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Marine Valery, Damien Vasseur, Francesco Fachinetti, Alice Boilève, Cristina Smolenschi, Anthony Tarabay, Leony Antoun, Audrey Perret, Alina Fuerea, Thomas Pudlarz, Valérie Boige, Antoine Hollebecque, Michel Ducreux
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments. Cancers 15 (18) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Clémence Flecchia, Edouard Auclin, Emily Alouani, Mathilde Mercier, Antoine Hollebecque, Anthony Turpin, Thibault Mazard, Simon Pernot, Marie Dutherage, Romain Cohen, Christophe Borg, Vincent Hautefeuille, Francesco Sclafani, Meher Ben-Abdelghani, Thomas Aparicio, Christelle De La Fouchardière, Camille Herve, Geraldine Perkins, Kathrin Heinrich, Volker Kunzmann, Claire Gallois, Rosine Guimbaud, David Tougeron, Gilles Manceau
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. British journal of cancer 130 (3) (2023)
Mihaela Aldea, Marco Tagliamento, Arnauld Bayle, Damien Vasseur, Véronique Vergé, Arianna Marinello, François-Xavier Danlos, Félix Blanc-Durand, Elsa Bernard, Luigi Cerbone, Maria Fernanda Mosele, Aline Renneville, Julien Hadoux, Yohann Loriot, Madona Sakkal, Aurore Vozy, Clementine Sarkozy, Cristina Smolenschi, Claudio Nicotra, Patricia Martin-Romano, Clementine Boccon-Gibod, Wafikaamira Habza, Julien Lazarovici, Santiago Ponce, Antoine Hollebecque, Christophe Marzac, Ludovic Lacroix, Fabrice Barlesi, Fabrice Andre, Benjamin Besse, Etienne Rouleau, Antoine Italiano, Jean-Baptiste Micol
Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors. JCO precision oncology 7 (2023)
Francesco Facchinetti, Antoine Hollebecque, Floriane Braye, Damien Vasseur, Yoann Pradat, Rastislav Bahleda, Cedric Pobel, Ludovic Bigot, Olivier Deas, Juan David Florez Arango, Giorgia Guaitoli, Hayato Mizuta, David Combarel, Lambros Tselikas, Stefan Michiels, Sergey I Nikolaev, Jean Yves Scoazec, Santiago Ponce-Aix, Benjamin Besse, Ken A Olaussen, Yohann Loriot, Luc Friboulet
Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer. Cancer discovery (2023)
Benoit Rousseau, Ivan Bièche, Éric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Lucas Michon, Aurélien de Reyniès, Valerie Attignon, Michael B Foote, Julien Masliah-Planchon, Magali Svrcek, Romain Cohen, Victor Simmet, Paule Augereau, David Malka, Antoine Hollebecque, Damien Pouessel, Carlos Alberto Gomez Roca, Rosine Guimbaud, Amandine Bruyas, Marielle Guillet, Jean-Jacques Grob, Muriel Duluc, Sophie Cousin, Christelle De La Fouchardière, Aude Flechon, Frédéric Rolland, Sandrine Hiret, Esma Saada-Bouzid, Olivier Bouche, Thierry André, Diane Pannier, Farid El Hajbi, Stephane Marie Oudard, Christophe Tournigand, Jean-Charles Soria, Stephane Champiat, Drew G Gerber, Dennis Stephens, Michelle F Lamendola-Essel, Steven B Maron, Bill H Diplas, Guillem Argilés, Asha R Krishnan, Séverine Tabone-Eglinger, Anthony Ferrari, Neil H Segal, Andrea Cercek, Natalie Hoog-Labouret, Frederic Legrand, Clotilde Simon, Assia Lamrani-Ghaouti, Luis A Diaz, Pierre Saintigny, Sylvie Chevret, Aurélien Marabelle
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon. Cancer discovery 12 (6) (2022)
Marine Valery, Baptiste Cervantes, Ramy Samaha, Maximiliano Gelli, Cristina Smolenschi, Alina Fuerea, Lambros Tselikas, Caroline Klotz-Prieux, Antoine Hollebecque, Valérie Boige, Michel Ducreux
Immunotherapy and Hepatocellular Cancer: Where Are We Now? Cancers 14 (18) (2022)
Damien Vasseur, Hela Sassi, Arnaud Bayle, Marco Tagliamento, Benjamin Besse, Christophe Marzac, Ahmadreza Arbab, Nathalie Auger, Sophie Cotteret, Mihaela Aldea, Félix Blanc-Durand, Arthur Geraud, Anas Gazzah, Yohann Loriot, Antoine Hollebecque, Patricia Martín-Romano, Maud Ngo-Camus, Claudio Nicotra, Santiago Ponce, Madona Sakkal, Olivier Caron, Cristina Smolenschi, Jean-Baptiste Micol, Antoine Italiano, Etienne Rouleau, Ludovic Lacroix
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved Test. Cells 11 (12) (2022)
Manish A Shah, Takashi Kojima, Daniel Hochhauser, Peter Enzinger, Judith Raimbourg, Antoine Hollebecque, Florian Lordick, Sung-Bae Kim, Masahiro Tajika, Albert Craig Lockhart, Hendrick-Tobias Arkenau, Farid El-Hajbi, Mukul Gupta, Per Pfeiffer, Pooja Bhagia, Zhu Alexander Cao, Jared Lunceford, Shailaja Suryawanshi, Mark Ayers, Matthew J Marton, Ken Kato
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer. Future oncology (London, England) (2022)
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Patricia Niccoli, Jaume Capdevila, Curigliano Giuseppe, Victor Moreno, Filippo de Braud, Sonia Gonzalez de Villambrosia, Patricia Martin-Romano, Eric Baudin, Marina Arias, Juan de Alvaro, Josep L Parra-Palau, Tania Sánchez-Pérez, Ida Aronchik, Ellen H Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S de Bono
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Cancer 128 (17) (2022)
Monica Pierro, Capucine Baldini, Edouard Auclin, Hélène Vincent, Andreea Varga, Patricia Martin Romano, Perrine Vuagnat, Benjamin Besse, David Planchard, Antoine Hollebecque, Stéphane Champiat, Aurélien Marabelle, Jean Marie Michot, Christophe Massard, Laura Mezquita
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score. Cancers 14 (20) (2022)
Quang Loc Bui, Léo Mas, Antoine Hollebecque, David Tougeron, Christelle De La Fouchardière, Thomas Pudlarz, Emily Alouani, Rosine Guimbaud, Gilles Manceau, Thierry André, Raphaël Colle, Romain Cohen
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer. Cancers 14 (2) (2022)
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, Ludovic Lacroix, Etienne Rouleau, Anas Gazzah, Rastilav Bahleda, David Planchard, Andrea Varga, Capucine Baldini, Sophie Postel-Vinay, Luc Friboulet, Yohann Loriot, Loic Verlingue, Arthur Geraud, Maud Ngo Camus, Claudio Nicotra, Jean Charles Soria, Fabrice André, Benjamin Besse, Christophe Massard, Antoine Italiano
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology. JCO precision oncology 6 (2022)
George D Demetri, Jason John Luke, Antoine Hollebecque, John D Powderly, Alexander I Spira, Vivek Subbiah, Louie Naumovski, Chris Chen, Hua Fang, Dominic W Lai, Huibin Yue, Akshanth R Polepally, James W Purcell, Randy R Robinson, Padmanee Sharma, James P Allison, Anthony Tolcher, Victor M Villalobos
First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Alice Boilève, Marc Hilmi, Cristina Smolenschi, Michel Ducreux, Antoine Hollebecque, David Malka
Immunotherapy in Advanced Biliary Tract Cancers. Cancers 13 (7) (2021)
Edouard Auclin, Perrine Vuagnat, Cristina Smolenschi, Gilles Manceau, Jorge Adeva, Laetitia Nebot-Bral, Marta Garcia de Herreros, Rosario Vidal Tocino, Federico Longo-Muñoz, Yola El Dakdouki, Patricia Martín-Romano, Lydia Gaba, Tamara Saurí, Helena Oliveres, Eduardo Castañón, Rocio Garcia-Carbonero, Benjamin Besse, Christophe Massard, Laura Mezquita, Antoine Hollebecque
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors. Cancers 13 (15) (2021)
Antoine Hollebecque, Hyun C Chung, Maria J de Miguel Luken, Antoine Italiano, Jean-Pascal Machiels, Chia-Chi Lin, Neesha C Dhani, Marc Peeters, Victor Moreno, Wu-Chou Su, Kay Hoong Chow, Violeta R Galvao, Michelle Carlsen, Danni Yu, Anna M Szpurka, Yumin Zhao, Shelly L Schmidt, Leena Gandhi, Xiaojian Xu, Yung-Jue Bang
Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Julie Delorme, Valentin Charvet, Muriel Wartelle, François Lion, Bruno Thuillier, Sandrine Mercier, Jean-Charles Soria, Mikael Azoulay, Benjamin Besse, Christophe Massard, Antoine Hollebecque, Loic Verlingue
Natural Language Processing for Patient Selection in Phase I or II Oncology Clinical Trials. JCO clinical cancer informatics 5 (2021)
Ian M Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert C Newton, Huiling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C Burn
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib. Cancer discovery 11 (2) (2020)
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Nicolas Isambert, Patricia Niccoli, Jaume Capdevila, Curigliano Giuseppe, Victor Moreno, Patricia Martin-Romano, Eric Baudin, Marina Arias, Sheila Mora, Juan de Alvaro, Jorge Di Martino, Josep L Parra-Palau, Tania Sánchez-Pérez, Ida Aronchik, Ellen H Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S de Bono
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Gary M Middleton, Yiqun Yang, Catarina D Campbell, Thierry André, Chloe E Atreya, Jan H M Schellens, Takayuki Yoshino, Johanna C Bendell, Antoine Hollebecque, Autumn J McRee, Salvatore Siena, Michael S Gordon, Josep Tabernero, Rona Yaeger, Peter J O'Dwyer, Filip De Vos, Eric Van Cutsem, John M Millholland, Jan C Brase, Fatima Rangwala, Eduard Gasal, Ryan B Corcoran
BRAF-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Andrea Varga, Jean-Charles Soria, Antoine Hollebecque, Patricia LoRusso, Johanna Bendell, Shih-Min A Huang, Marie-Claire Wagle, Kwame Okrah, Lichuan Liu, Elaine Murray, Sandra M Sanabria-Bohorquez, Michael Tagen, Hatem Dokainish, Lars Mueller, Howard Burris
A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)
Francesco Facchinetti, Antoine Hollebecque, Rastislav Bahleda, Yohann Loriot, Ken A Olaussen, Christophe Massard, Luc Friboulet
Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (4) (2019)
Richard D Kim, Debashis Sarker, Tim Meyer, Thomas Yau, Teresa Macarulla, Joong-Won Park, Su Pin Choo, Antoine Hollebecque, Max W Sung, Ho-Yeong Lim, Vincenzo Mazzaferro, Joerg Trojan, Andrew X Zhu, Jung-Hwan Yoon, Sunil Sharma, Zhong-Zhe Lin, Stephen L Chan, Sandrine Faivre, Lynn G Feun, Chia-Jui Yen, Jean-François Dufour, Daniel H Palmer, Josep M Llovet, Melissa Manoogian, Meera Tugnait, Nicolas Stransky, Margit Hagel, Nancy E Kohl, Christoph Lengauer, Cori Ann Sherwin, Oleg Schmidt-Kittler, Klaus P Hoeflich, Hongliang Shi, Beni B Wolf, Yoon-Koo Kang
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma. Cancer discovery 9 (12) (2019)
Ryan J Sullivan, Antoine Hollebecque, Keith T Flaherty, Geoffrey I Shapiro, Jordi Rodon Ahnert, Michael J Millward, Wei Zhang, Ling Gao, Amanda Sykes, Melinda D Willard, Danni Yu, Andrew E Schade, KrisAnne Crowe, Daniel L Flynn, Michael D Kaufman, James R Henry, Sheng-Bin Peng, Karim A Benhadji, Ilaria Conti, Michael S Gordon, Ramon V Tiu, David S Hong
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer. Molecular cancer therapeutics 19 (2) (2019)
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z Rizvi, Rosa L Frias, Jean-Paul Thiery, Jean-Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Deas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Braye, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo-Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry De Baere, Lambros Tselikas, Eric Solary, Eric Angevin, Alexander M Eggermont, Fabrice Andre, Christophe Massard, Ken A Olaussen, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (1) (2019)
Sumitra Mohan, Mahmood Ayub, Dominic G Rothwell, Sakshi Gulati, Bedirhan Kilerci, Antoine Hollebecque, Hui Sun Leong, Nigel K Smith, Sudhakar Sahoo, Tine Descamps, Cong Zhou, Richard A Hubner, Mairéad Geraldine McNamara, Angela Lamarca, Juan W Valle, Caroline Dive, Ged Brady
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer. Scientific reports 9 (1) (2019)
Marie-Léa Gauci, Emilie Lanoy, Stéphane Champiat, Caroline Caramella, Samy Ammari, Sandrine Aspeslagh, Andrea Varga, Capucine Baldini, Rastilav Bahleda, Anas Gazzah, Jean-Marie Michot, Sophie Postel-Vinay, Eric Angevin, Vincent Ribrag, Antoine Hollebecque, Jean-Charles Soria, Caroline Robert, Christophe Massard, Aurélien Marabelle
Long-Term Survival in Patients Responding to Anti-PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (3) (2018)

Antoine Hollebecque.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antoine Hollebecque